Remdesivir for 5 or 10 Days in Patients with Severe Covid-19

BACKGROUND: Remdesivir is an RNA polymerase inhibitor with potent antiviral activity in vitro and efficacy in animal models of coronavirus disease 2019 (Covid-19). METHODS: We conducted a randomized, open-label, phase 3 trial involving hospitalized patients with confirmed SARS-CoV-2 infection, oxyge...

Fuld beskrivelse

Na minha lista:
Bibliografiske detaljer
Udgivet i:N Engl J Med
Main Authors: Goldman, Jason D., Lye, David C.B., Hui, David S., Marks, Kristen M., Bruno, Raffaele, Montejano, Rocio, Spinner, Christoph D., Galli, Massimo, Ahn, Mi-Young, Nahass, Ronald G., Chen, Yao-Shen, SenGupta, Devi, Hyland, Robert H., Osinusi, Anu O., Cao, Huyen, Blair, Christiana, Wei, Xuelian, Gaggar, Anuj, Brainard, Diana M., Towner, William J., Muñoz, Jose, Mullane, Kathleen M., Marty, Francisco M., Tashima, Karen T., Diaz, George, Subramanian, Aruna
Format: Artigo
Sprog:Inglês
Udgivet: Massachusetts Medical Society 2020
Fag:
Original Article
Online adgang:https://ncbi.nlm.nih.gov/pmc/articles/PMC7377062/
https://ncbi.nlm.nih.gov/pubmed/32459919
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1056/NEJMoa2015301
Tags: Tilføj Tag
Ingen Tags, Vær først til at tagge denne postø!

Lignende værker